Accounting for concurrent antihyperglycemic medication changes in dietary and physical activity interventions: A focused literature review

Diab Vasc Dis Res. 2022 May-Jun;19(3):14791641221111252. doi: 10.1177/14791641221111252.

Abstract

Aims: To summarize methods used to account for antihyperglycemic medication changes in randomized controlled trials evaluating the effect of dietary and physical activity interventions on glycemia among adults with diabetes.

Methods: Using studies included in two recently published systematic reviews of randomized controlled trials examining the glycemic effects of dietary and physical activity interventions, we evaluated how each study accounted for antihyperglycemic medication changes. Data were analyzed using summary statistics, stratified by the type of intervention studied, and each was assigned a score from 0 to 6 reflecting the strength of medication controls employed.

Results: We evaluated 22 physical activity focused and 27 dietary focused articles. Our scoring system yielded a mean concurrent medication adjustment score of 3.9/6 for the physical activity studies and a score of 1.7/6 (p < 0.001) for the dietary studies.

Conclusions: We found that randomized controlled trials included in recent systematic reviews of physical activity and dietary interventions did not robustly account or control for changes in antihyperglycemic medications, with physical activity interventions doing so more robustly than dietary interventions. This is a threat to the validity of study findings, as observed glycemic changes may in fact be attributable to imbalances in concurrent medication adjustments between groups.

Keywords: Type 2 diabetes; diet; lifestyle intervention; physical activity; randomized controlled trial.

Publication types

  • Review

MeSH terms

  • Blood Glucose
  • Diet
  • Exercise*
  • Humans
  • Hypoglycemic Agents* / adverse effects

Substances

  • Blood Glucose
  • Hypoglycemic Agents